The HHS Office of Inspector General is seeking public comment on whether to protect payments to clinical trial participants, a move supported by research showing that compensating individuals—including those who use drugs—is essential for developing effective medical treatments.
The HHS Office of Inspector General is seeking public comment on whether to protect payments to clinical trial participants, a move supported by research showing that compensating individuals—including those who use drugs—is essential for developing effective medical treatments.
<iframe src="https://statesidedaily.com/embed/cluster/07833253f6f8430249cdd05d78b208fc57d61ac9" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="HHS should protect payments to clinical trial participants"></iframe>
